The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.

Oncology reports

Volumn 14, Issue 5, 2005, Pages 1357-1363

  Greene, Lisa M ^a   Fleeton, Marina ^a   Mulligan, Jude ^a   Gowda, Chikkanna ^a   Sheahan, Brian J ^a   Atkins, Gregory J ^a   Campiani, Giuseppe ^a   Nacci, Vito ^a   Lawler, Mark ^a   Williams, D Clive ^a   Zisterer, Daniela M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; OXAZEPINE DERIVATIVE; PBOX 6; PBOX-6; PYRROLE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; DRUG EFFECT; FEMALE; HUMAN; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL SURVIVAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; OXAZEPINES; PYRROLES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 27744573115     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.14.5.1357     Document Type: Article

References (0)